Peptide Derivatives Of Cytochrome b558 And Their Use As Medicaments [As Anti-Inflammatory Agents]


A new anti-inflammatory agent based on two c-terminal amino acid sequences of cytochrome b558 has been shown to inhibit the production of toxic oxygen products (superoxide, peroxide) by human phagocytic cells. Because of its specificity for phagocytic cells, it is expected that these peptide derivatives would not have the side effects of other anti-inflammatory agents in general use.

Inventors:

Harry Malech (NIAID)  ➽ more inventions...

Karen Lomax (NIAID)  ➽ more inventions...

Daniel Rotrosen ()  ➽ more inventions...

Hiroyuki Nunoi ()  ➽ more inventions...


Intellectual Property:
U.S. Pat: 5,585,346 issued 1996-12-17

Licensing Contact:
Admin. Licensing Specialist (ALS),
Email:
Phone:

OTT Reference No: E-263-1988-0
Updated: Feb 1, 1996